103
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

First Study of NAT1 and NAT2 Polymorphisms in Bulgarian Patients with Balkan Endemic Nephropathy (Ben) and Healthy Controls

, , , &
Pages 95-103 | Published online: 15 Apr 2014

REFERENCES

  • Puchlev A., Dimitrov T., Dinev I., Doichinov D. (1979) Clinical investigations in patients with endemic nephropathy. In: Endemic (Balkan) Nephropathy, Niš, (S. Strahinjić, V. Stefanović, eds.) University press, 7–10.
  • Toncheva D., Dimitrov T., Stoyanova S. (1998) Eur J Epid; 14, 389–94.
  • Stefanivić V. (1998) Q. J. Med. 1998, 91, 457–63.
  • Feder G., Radovanovich A., Finkelman R. (1991) Relationship between weathered coal deposits and the etiology of Balkan endemic nephropathy. Kidney Int Suppl 1991, 34, S9–11.
  • Orem W., Feder G., Finkelnman R. (1999) J. of Coal Geology, 40, 3237–52.
  • Voice T., McElmurry S., Long D., Petropoulos E., Ganev V. (2002) Evaluation of coal leachate contamination of water supplies as a hypothesis for the occurrence of Balkan endemic nephropathy in Bulgaria. Facta Universitatis, Series Medicine and Biology, 9, 128–9.
  • Stefanovic V. (2002) Analgesic nephropathy, Balkan endemic nephropathy and Chinese herbs nephropathy: separate tubulointerstitial kidney diseases associated with urothelial malignancy. Facta Universitatis, Series Medicine and Biology, 9, 1–6.
  • Brockmoller J., Cascorbi I., Henning S., Meisel C., Roots I. (2000) Pharmacology, 61, 212–27.
  • Hein D., Doll M., Rustan T., Gray K., Feng Y., Ferguson R., Grant D. ( 1993) Carcinogenesis, 14: 1633–38.
  • Hein D., Rustan T., Doll M., Bucher K., Ferguson R., Feng Y., Furman E., Gray K. (1992) Toxicol Lett, 64–65, 123–30
  • Grant D., Hughes N., Janezic S., Goodfellow G., Chen H., Gaedigk A., Yu VL, Grewal R. (1997) Mutat. Res., 376, 61–70
  • Hein D., Doll M., Fretland A., Leff M., Webb S., Xiao G., Devanaboyina U., Nangju N., Feng Y. (2000) Cancer Epidemiol Biomarkers Prev, 9, 29–42.
  • Cascorbi I., Roots I. (1999) Pharmacogenetics, 9, 123–7.
  • Hein D. Biochim Biophys Acta 1988, 948, 37–66.
  • Cartwright R., Glashan R., Rogers H., Ahmad R., Barham-Hall D., Higgins E., Kahn M. (1982) Lancet, 2, 842–5.
  • Longuemaux S., Delomenie C., Gallou C., Mejean A., Vincent-Viry M., Bouvier R., Droz D., Krishnamoorthy R., Galteau M., Junien C., Beroud C., Dupret J. (1999) Cancer Res., 59, 2903–8.
  • Bruhn C., Brockmöller J., Cascorbi I., Roots I., Borchert H. ( 1999) Biochem Pharmacol, 58, 1759–64.
  • Bell D., Stephens E., Castranio T., Umbach D., Watson M., Deakin M., Elder J., Duncan H., Hendrickse C., Strange R. (1995) Cancer Res., 55, 3537–42.
  • Taylor J., Umbach D., Castranio T., Paulson D., Robertson C., Mohler J., Bell D. (1998) ancer Res., 58, 3603–10.
  • Cascorbi I., Roots I., Brockmoller J. (2001) Cancer Res., 61, 5051–6.
  • Miller S., Dykes D., Polesky H: ( 1988) Nucleic Acids Res., 16,1215.
  • von Ahsen N., Oellerich M., Armstrong V., Schütz E. (1999) Clin Chem., 45, 2094–210.
  • Abramson J., Gahlinger P. (1999) Computer programs for Epidemiologists: PEPI Version 3. Brixton Books, Llanindloes, Powys, Wales.
  • Labuda D., Krajinovic M., Richer C., Skoll A., Sinnett H., Yotova V., Sinnett D. (1999) Anal Biochem., 275, 84–92.
  • Hughes N., Janezic S., McQueen K., Jewett M., Castranio T., Bell D., Grant D. (1998) Pharmacogenetics, 8, 55–66.
  • Toncheva D., Dimitrov T. (1996) Nephron, 72, 564–69.
  • Radovanovic Z., Sindic M., Polenakovic M., Dukanovic L., Petronic V. (2000) In: Endemic Nephropathy Belgrad, (Z. Radovanovic, Ed.), Zavod za Udzbenike I Nastavna Sredstva.
  • Vaziri S., Hughes N., Sampson H., Darlington G., Jewett M., Grant D. (2001) Pharmacogenetics, 11, 7–20.
  • Stanley L., Coroneos E., Cuff R., Hickman D., Ward A., Sim E. (1996) J. Histochem Cytochem, 44, 1059–67.
  • Agundez J., Ladero J., Olivera M., Lozano L., Fernandez-Arquero M., de la Concha E., Diaz-Rubio M., Benitez J. (2002) Scand. J. Gastroenterol, 37, 99–103.
  • Dimitrov T. (2002) Balkan endemic nephropathy in Bulgaria Facta Universitatis, Series Medicine and Biology, 9, 7–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.